To determine whether cell-of-origin also affects development and phenotype of HER2-amplified tumours, we used our cell type-targeted promoter approach to activate the NeuNT allele in either basal or luminal ER− mammary epithelial populations. The gene discussed is ERBB2; the disease is neoplasm.